OMNIAB, INC. Unrealized Gain (Loss) on Investments
OMNIAB, INC. (OABI) reported Unrealized Gain (Loss) on Investments of $51.28 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2022-05-20
- OMNIAB, INC. unrealized gain (loss) on investments for the quarter ending 2022-03-31 was $51.28K.
| Period end | Unrealized Gain (Loss) on Investments 3 month |
|---|---|
| 2022-03-31 | $51.28K 10-Q · filed 2022-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |